SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients
Public ClinicalTrials.gov record NCT04154956. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Open-label, Phase 3 Study of SAR408701 Versus Docetaxel in Previously Treated, Metastatic Nonsquamous, Non-small-cell Lung Cancer Patients With CEACAM5-positive Tumors
Study identification
- NCT ID
- NCT04154956
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 389 participants
Conditions and interventions
Conditions
Interventions
- Docetaxel Drug
- SAR408701 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2020
- Primary completion
- Sep 21, 2023
- Completion
- Mar 30, 2026
- Last update posted
- Aug 4, 2025
2020 – 2026
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Cancer Specialists South Division- Site Number : 8400020 | Fort Myers | Florida | 33901 | — |
| Florida Cancer Specialists North Division- Site Number : 8400019 | St. Petersburg | Florida | 33705 | — |
| Ca & Hem Center Of W Michigan- Site Number : 8400016 | Grand Rapids | Michigan | 49546 | — |
| Roswell Park Cancer Institute Site Number : 8400011 | Buffalo | New York | 14263-0001 | — |
| Lankenau Hospital Cancer Center- Site Number : 8400017 | Wynnewood | Pennsylvania | 19096-3411 | — |
| Renovatio Clinical- Site Number : 8400032 | El Paso | Texas | 79915 | — |
| Renovatio Clinical - Site Number : 8400013 | The Woodlands | Texas | 77380 | — |
| Medical College of Wisconsin- Site Number : 8400006 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 161 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04154956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2025 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04154956 live on ClinicalTrials.gov.